SEMATECH Appoints New President and CEO

SEMATECH, the global consortium of semiconductor manufacturers, today announced that it has named Daniel Armbrust to serve as its President and Chief Executive Officer. Armbrust will succeed Michael R. Polcari, who has been appointed SEMATECH's Chairman of the Board.

Armbrust, 47, most recently served as Vice President of 300mm Semiconductor Operation, where he was responsible for the operation of IBM's 300mm fab in East Fishkill, New York, which develops leading edge technologies with IBM's alliance partners and manufactures products for IBM and OEM customers. Previously Armbrust held a variety of positions at IBM related to process development, manufacturing, and client engagement.

Michael Polcari, SEMATECH's newly appointed Chairman of the Board, said that the SEMATECH Board selected Armbrust to lead the consortium based on his track record of leadership and execution in developing leading edge technologies, directing fab operations, and managing complex alliances.

“Our search for a new leader for SEMATECH was focused and thorough,” said Polcari. “Dan came to our attention because of his proven ability to lead top performing teams, his strong credentials in both R&D and manufacturing, and his experience in driving strategic alliances. Dan has the right blend of talents for the job, and we are delighted to welcome him to SEMATECH.”

Armbrust said, “SEMATECH is one of the world's leading consortia, with a proud history, outstanding talent and significant technical innovations in many of its programs. SEMATECH has played a pivotal role in our industry, and it's a great honor to join its leadership team and have the opportunity to build on its success.”

Armbrust will assume his new duties immediately, replacing Michael R. Polcari, who has been SEMATECH's President and CEO since February 2003. Polcari succeeds OB Bilous as Chairman of SEMATECH's Board of Directors.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.